This biotech making precision medicines for cancer could nearly triple, says JPMorgan
- Posted on October 1, 2026
- By CNBC
- 1 Views
- 1 min read
In brief
Generating AI summary…
This biotech making precision medicines for cancer could nearly triple, says JPMorgan
Kura Oncology's pipeline of drugs show promise for the biotech stock.